
### [NCIT:C8669](http://purl.obolibrary.org/obo/NCIT_C8669)
**Label:** Refractory Nasal Type Extranodal NK/T-Cell Lymphoma

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38996](http://purl.obolibrary.org/obo/NCIT_C38996) (ATM Signaling Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 36.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 36.67%


